Is the Direct Inferior Alveolar Nerve Block Required for Third Lower Molar Extraction?

• Status: Completed
• Trial end date: 2018-12-20
• Target enrollment: 0
• Participant gender: All

Summary

This study is a Randomized Controlled Trial (RCT) which objective is to compare the effectiveness, efficacy and complication associated to an infiltrative anesthetic technique for the removal of lower third molars comparing it to the standard inferior alveolar nerve block using 4% articaine 1:100.000 epinephrine.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Barcelona
• Treatments: Anesthetics; Carticaine; Epinephrine; Epinephryl borate; Racepinephrine

Criteria

Inclusion Criteria:

• Lower third molars in any position (in accordance to Pell and Gregory and Winter classification) in need of extraction.

• Healthy patients and patients with mild systemic disease without substantive functional limitations (ASA I-II).

• Absence of acute infection in the third molar area.

• Adequate intellectual capacity for understanding the nature and purpose of the study and fill the informed consent and questionaries appropriately.

Exclusion Criteria:

• History of recent trauma in the maxillofacial area.

• Articaine or lidocaine allergy.

• Presence of a systemic pathology that contraindicates the use of local anesthetics with vasopressors.

• Acute infection in the third molar area (in the las 30 days).

• Surgeries taking more than 60 minutes (automatic dropout).

• Unwillingness to participate or continue participating in the study.

• A score equal or superior to 13 points in the Corah´s anxiety test.

• Third molars in ectopic position.

• Caries on the third molar.